Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
about
Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Melanoma epidemiology, biology and prognosis.Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi.Evaluating biomarkers in melanoma.Prognostic survival model for people diagnosed with invasive cutaneous melanoma.Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements.Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.A review of sentinel lymph node biopsy for thin melanoma.Sentinel lymph node biopsy for cutaneous head and neck malignancies.Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis.Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.Miscoding of Melanoma Thickness in SEER: Research and Clinical Implications.TRPM1 (melastatin) expression is an independent predictor of overall survival in clinical AJCC stage I and II melanoma patients.Use of support services in a sample of patients with high-risk primary melanomas in urban, regional and rural Queensland.Survival outcomes in patients with multiple primary melanomas.Melanoma survival is superior in females across all tumour stages but is influenced by age.Can we better identify thin cutaneous melanomas that are likely to metastasize and cause death?Prognostic sub-classifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark level of invasion. Results of a population-based study from the Swedish Melanoma Register.Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.Disparities in melanoma incidence rates in Europe.Fear of new or recurrent melanoma after treatment for localised melanoma.Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives.Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia.Reply: Increased mortality for pregnancy-associated melanoma: systematic review and meta-analysis.Primary Prevention of Skin CancerPARP1polymorphisms play opposing roles in melanoma occurrence and survivalMetastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile
P2860
Q30252150-06A435D4-43E0-410C-8F7E-01136B4CF79EQ33698718-B01ACA44-A299-42EC-BAE8-4A4438701561Q34337898-DF844632-267A-4A48-A0F4-4C3F33D048DCQ35005677-B414961D-2C1D-4E64-9522-99486EEB9D69Q35083406-B57F1C27-9BA6-4FB8-B9A0-F401F6411934Q35801085-AB7E3A93-0808-42AF-99D4-CB83053D6656Q35910958-356089FA-8249-490E-91BF-DB225C3CBC51Q37289626-9C1DA602-B92A-4C4F-A9DD-B70396D05DC1Q38264727-6583FA09-ACAD-4C57-9A29-CF9AFABE152BQ38286125-AF500AFF-9A08-494D-941C-784A1DD3112BQ38358882-68D30B4E-C8E4-446A-A35A-DB505F9DCD2CQ38407303-89921EBA-4CD6-424C-A906-31C1F8392D83Q39106275-1057D76C-756D-4C92-A70F-B091D2BA4DAAQ39647230-470C4B1E-6257-470A-810C-809F8B2CB676Q40420126-2AB59AC4-950A-4209-B669-AAA74EC08C41Q40458333-FF82FA26-F724-40AB-897A-B78897B83A0BQ41087096-9A235282-B697-4886-8954-879D05FF5B77Q41647358-8AFCA456-FFFF-4D0F-8179-09260C69DD33Q44652712-EE8FB117-765F-4469-B393-630D295D4B9DQ44835457-3A1FFB2E-180B-4AE0-B20B-3D4005FEF444Q45102326-53B33B51-B98A-4130-8DB0-0144657C2A3AQ45290007-7C03FFB1-6C75-49E3-ABF8-2688EED2B727Q47357097-95E07CD1-358C-4886-AB3D-885439F8C33CQ47375181-A65540BD-EFD2-481D-B56D-34EA9424D42AQ47398159-45FFE924-B8B7-41C0-876C-1675E207C803Q47660640-1B360C80-FC0B-4C4B-B014-E81DBD4F72FFQ47803820-AEF93163-F91D-4A9F-8FC0-87299003AEC9Q50057706-7D2FF75C-BCEF-46F7-A885-C9BFB6FC3C54Q50247600-6C20F6EC-5D39-46C8-A993-39F893F72A60Q50277017-880D2182-56BC-4062-9B6C-A74AA6965193Q56112839-4CBBF489-87FB-40D9-992D-B62F52799344Q57274179-40141489-4E13-4843-92D7-3AAFCFE127B8Q58780424-9274A71B-EED5-483F-9846-429F536B25B9
P2860
Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Population-based 20-year survi ...... omas in Queensland, Australia.
@en
Population-based 20-year survi ...... omas in Queensland, Australia.
@nl
type
label
Population-based 20-year survi ...... omas in Queensland, Australia.
@en
Population-based 20-year survi ...... omas in Queensland, Australia.
@nl
prefLabel
Population-based 20-year survi ...... omas in Queensland, Australia.
@en
Population-based 20-year survi ...... omas in Queensland, Australia.
@nl
P2093
P356
P1476
Population-based 20-year survi ...... omas in Queensland, Australia.
@en
P2093
Adèle C Green
Joanne F Aitken
Mark Smithers
Michael Coory
P304
P356
10.1200/JCO.2011.38.8561
P407
P577
2012-03-12T00:00:00Z